PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Cancer Research and Treatment10.4143/crt.2018.3752019513886-900Jab1 Silencing Inhibits Proliferation and Sensitizes to Cisplatin in Biliary Tract CancerAh-Rong Nam, Ji-Won Kim, Ji Eun Park, Ju-Hee Bang, Mei Hua Jin, Do-Youn Oh, Yung-Jue Banghttp://e-crt.org/upload/pdf/crt-2018-375.pdf, http://e-crt.org/journal/view.php?doi=10.4143/crt.2018.375, http://www.e-crt.org/upload/pdf/crt-2018-375.pdf
Annals of Oncology10.1093/annonc/mdx369.099201728v243Jab1 silencing inhibits proliferation and sensitizes to cisplatin in biliary tract cancerJ-W. Kim, A-R. Nam, J.E. Park, J-H. Bang, M.H. Jin, D-Y. Oh, Y-J. Banghttps://api.elsevier.com/content/article/PII:S0923753420379898?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0923753420379898?httpAccept=text/plain, http://academic.oup.com/annonc/article-pdf/28/suppl_5/mdx369.099/19939385/mdx369.099.pdf
Bioscience Reports10.1042/bsr201604452017372Protein kinase C β inhibits autophagy and sensitizes cervical cancer Hela cells to cisplatinNa Li, Wei Zhanghttp://portlandpress.com/bioscirep/article-pdf/doi/10.1042/BSR20160445/518487/bsr-2016-0445.pdf, http://portlandpress.com/bioscirep/article-pdf/doi/10.1042/BSR20160445/518487/bsr-2016-0445.pdf
Thoracic Cancer10.1111/1759-7714.1213020156131-37Silencing of tripartite motif (TRIM) 29 inhibits proliferation and invasion and increases chemosensitivity to cisplatin in human lung squamous cancer NCI-H520 cellsChunxiao Liu, Xiaoxi Huang, Shengcai Hou, Bin Hu, Hui Lihttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2F1759-7714.12130, http://onlinelibrary.wiley.com/wol1/doi/10.1111/1759-7714.12130/fullpdf
Cancer Letters10.1016/j.canlet.2010.03.0112010296127-34Silencing of Tousled-like kinase 1 sensitizes cholangiocarcinoma cells to cisplatin-induced apoptosisYuichi Takayama, Toshio Kokuryo, Yukihiro Yokoyama, Satoko Ito, Masato Nagino, Michinari Hamaguchi, Takeshi Sengahttps://api.elsevier.com/content/article/PII:S0304383510001485?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0304383510001485?httpAccept=text/plain
Yearbook of Surgery10.1016/s0090-3671(10)79889-x20112011310-312Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract CancerT.J. Eberleinhttps://api.elsevier.com/content/article/PII:S009036711079889X?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S009036711079889X?httpAccept=text/plain
Yearbook of Gastroenterology10.1016/s0739-5930(10)79580-52010201096-97Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract CancerR.K. Pearsonhttps://api.elsevier.com/content/article/PII:S0739593010795805?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0739593010795805?httpAccept=text/plain
Annals of Oncology10.1093/annonc/mdt203.120201324iv70Gemcitabine Plus Cisplatin Versus Gemcitabine Chemotherapy for Advanced Biliary Tract CancerJinmyung Park, Jikon Ryuhttps://api.elsevier.com/content/article/PII:S0923753419546026?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0923753419546026?httpAccept=text/plain, http://academic.oup.com/annonc/article-pdf/24/suppl_4/iv70/6676803/mdt203.120.pdf
FEBS Letters10.1016/j.febslet.2006.09.0422006580255836-5844Depletion of Jab1 inhibits proliferation of pancreatic cancer cell linesAkihisa Fukumoto, Kiichiro Tomoda, Noriko Yoneda-Kato, Yoshiyuki Nakajima, Jun-ya Katohttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1016%2Fj.febslet.2006.09.042, https://onlinelibrary.wiley.com/doi/full/10.1016/j.febslet.2006.09.042
Annals of Oncology10.1093/annonc/mdu334.108201425iv245Gemcitabine Plus Cisplatin Versus Capcitbine Plus Cisplatin for Locally Advanced or Metastatic Biliary Tract CancerK. Park, K. Kimhttps://api.elsevier.com/content/article/PII:S0923753419520476?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0923753419520476?httpAccept=text/plain, http://academic.oup.com/annonc/article-pdf/25/suppl_4/iv245/9690351/mdu334.108.pdf